These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 6172800)
1. The immunocytochemical detection of growth hormone and prolactin in human prostatic tissues. Harper ME; Sibley PE; Peeling WB; Griffiths K Prog Clin Biol Res; 1981; 75B():115-28. PubMed ID: 6172800 [No Abstract] [Full Text] [Related]
2. Immunocytochemical technique for detection of prolactin (PRL) and growth hormone (GH) in hyperplastic and neoplastic lesions of dog prostate and mammary gland. El Etreby MF; Mahrous AT Histochemistry; 1979; 64(3):279-86. PubMed ID: 93102 [TBL] [Abstract][Full Text] [Related]
3. Radio-ligand-receptor assay for human chorionic somatomammotropin (hCS), ovine prolactin (oPRL) and human growth hormone (hGH) using rat ventral prostate particles. Fabrizi P; Barbarulli G; Tarli P; Neri P Boll Soc Ital Biol Sper; 1980 Mar; 56(5):485-91. PubMed ID: 7387793 [TBL] [Abstract][Full Text] [Related]
4. The immunocytochemical detection of protein hormones in human prostatic tissues. Sibley PE; Harper ME; Joyce BG; Peeling WB; Griffiths K Prostate; 1981; 2(2):175-85. PubMed ID: 6170964 [TBL] [Abstract][Full Text] [Related]
6. [Expression and its significance of b-FGF in human benign prostatic hyperplasia and prostatic carcinoma tissues]. Wang FL; Wang H; Qin WJ; Wu GJ; Zhang G; Li KN Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):203-5. PubMed ID: 15191726 [TBL] [Abstract][Full Text] [Related]
7. Alterations in the expression of androgen receptor, wild type-epidermal growth factor receptor and a mutant epidermal growth factor receptor in human prostate cancer. Olapade-Olaopa EO; Moscatello DK; MacKay EH; Sandhu DP; Terry TR; Wong AJ; Habib FK Afr J Med Med Sci; 2004 Sep; 33(3):245-53. PubMed ID: 15819472 [TBL] [Abstract][Full Text] [Related]
8. Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia. Myers RB; Kudlow JE; Grizzle WE Mod Pathol; 1993 Nov; 6(6):733-7. PubMed ID: 7508115 [TBL] [Abstract][Full Text] [Related]
9. [Organ culture of human tissue as study model of hormonal and pharmacological regulation of benign prostatic hyperplasia and of prostatic cancer]. Janssen T; Kiss R; Schulman C Acta Urol Belg; 1995 Mar; 63(1):7-14. PubMed ID: 7537011 [TBL] [Abstract][Full Text] [Related]
10. [Immunohistological studies on the localization of STH and LTH in the anterior pituitary of various species]. Weidner W Beitr Pathol; 1972; 145(2):168-203. PubMed ID: 5063902 [No Abstract] [Full Text] [Related]
11. 20th annual meeting of the histochemical society, Atlantic City, April 12-13, 1969. Symposium on hormone localization in cells and tissues. Hunter RL J Histochem Cytochem; 1970 Jan; 18(1):1-8. PubMed ID: 4190172 [No Abstract] [Full Text] [Related]
12. A growth factor in extracts of human prostatic tissue. Lawson RK; Story MT; Jacobs SC Prog Clin Biol Res; 1981; 75A():325-36. PubMed ID: 6175979 [No Abstract] [Full Text] [Related]
13. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia. Jackson MW; Bentel JM; Tilley WD J Urol; 1997 Jun; 157(6):2323-8. PubMed ID: 9146664 [TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone--related protein (PTHrP) is an epidermal growth factor-regulated secretory product of human prostatic epithelial cells. Cramer SD; Peehl DM; Edgar MG; Wong ST; Deftos LJ; Feldman D Prostate; 1996 Jul; 29(1):20-9. PubMed ID: 8685051 [TBL] [Abstract][Full Text] [Related]
15. [Immunochemical approach in the study of growth hormone and prolactin]. Zenkevich GA Usp Sovrem Biol; 1980; 90(1):97-107. PubMed ID: 7415510 [No Abstract] [Full Text] [Related]
16. [Determination of angiotensin converting enzyme in prostate diseases]. Van Camp K; Van Sande M; Neels H Verh K Acad Geneeskd Belg; 1985; 47(4):287-302. PubMed ID: 2417428 [No Abstract] [Full Text] [Related]
17. [Expression of kinase insert domain-containing receptor in prostate adenocarcinoma]. Bai AS; Zeng H; Li X; Wei Q; Li H; Yang YR Zhonghua Nan Ke Xue; 2007 Apr; 13(4):324-6. PubMed ID: 17491265 [TBL] [Abstract][Full Text] [Related]
18. Zinc and magnesium in human prostate gland: normal, hyperplastic, and neoplastic. Györkey F; Min KW; Huff JA; Györkey P Cancer Res; 1967 Aug; 27(8):1348-53. PubMed ID: 4167368 [No Abstract] [Full Text] [Related]
19. The application of immunoperoxidase methodology for the visualization of prolactin binding sites in human prostate tissue. Witorsch RJ Hum Pathol; 1979 Sep; 10(5):521-32. PubMed ID: 93568 [TBL] [Abstract][Full Text] [Related]
20. Variation of M3 muscarinic receptor expression in different prostate tissues and its significance. Song W; Yuan M; Zhao S Saudi Med J; 2009 Aug; 30(8):1010-6. PubMed ID: 19668880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]